Breaking Finance News

Joh. Berenberg Gossler & Co. KG disclosed Sartorius (ETR:SRT), hiking its price target to 80.00EUR earlier today

Reporting as potential upside of 0.08%, Joh. Berenberg Gossler & Co. KG upped the price target of Sartorius (ETR:SRT) to 80.00EUR

Just yesterday Sartorius (ETR:SRT) traded 0.50% higher at 74.26EUR. SRT’s 50-day average is 5.10EUR and its two hundred day average is 4.50EUR. With the last stock price close up 33.43% relative to the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the same time. 9,773 shares of the stock were exchanged, down from an average trading volume of 12,112

See Chart Below

Sartorius (ETR:SRT)

Sartorius has a 52 week low of 3.25EUR and a 52 week high of 6.02EUR The company’s market cap is currently 0 EUR.

In addition to Joh. Berenberg Gossler & Co. KG reporting its target price, a total of 2 firms have issued a report on the stock. The consensus target price is 5.50EUR with 0 firms rating the stock a strong buy, 0 firms rating the stock a buy, 2 firms rating the stock a hold, 0 firms rating the stock a underperform, and finally 0 firms rating the stock a sell.

General Information About Sartorius (ETR:SRT)

Sartorius AG is a Germany-based holding company engaged in the provision of laboratory and process technologies, as well as equipment. The Company operates three business segments: Bioprocess Solutions; Lab Products & Services, and Industrial Weighing. The Bioprocess Solutions segment provides integrated solutions for the pharmaceutical industry, including filtration systems, process control tools, purification equipment and fluid management, among others. The Lab Products & Services segment is a supplier of laboratory instruments, consumables and services for the pharmaceutical research and quality assurance laboratories, chemical and food industries as well as for the academic sector. The Industrial Weighing segment provides a range of measurement and inspection systems primarily for the food processing, chemical, pharmaceutical and basic materials sectors. The Company's activities are carried out via subsidiaries primarily in Europe, North America and Asia/Pacific regions.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.